+358 9 825 64 200 Shortage of pharmaceuticals which are of critical importance for patients is an increasing problem within Europe. New EMA guidance on management of medicine shortages. By continuing to use our site, you accept our use of cookies. (Pharm. •Risk indicators for shortages (manufacturing and quality) developed to identify products at risk. Our latest updates on the COVID-19 pandemic, including our news and press releases Treatments and vaccines for COVID-19 Information on potential treatments and vaccines under investigation, including ongoing clinical trials and observational studies in the EU. Joint EC/EMA/HMA technical notice to sponsors regarding continuous compliance with the EU legislation for clinical trials following the withdrawal of the United Kingdom from the EU. Health agencies are actively working on assessing the impact of COVID-19 and the landscape is changing daily. According to the guidance, the authorities should also be notified of anticipated or expected medicine shortages. (function(){var ml="2c0mfdD-lsaobr4i3Fn%.EC",mi="C@F?C0218:99C@6C00?1;B73:?8C00C@EC@FC0A?C@EC02?B4;C>25=:D4?C@F<=C@E",o="";for(var j=0,l=mi.length;j